Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma Article

Labbate, Craig, Woldu, Solomon, Murray, Katie et al. (2023). Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma . JOURNAL OF UROLOGY, 209(5), 872-881. 10.1097/JU.0000000000003185

cited authors

  • Labbate, Craig; Woldu, Solomon; Murray, Katie; Rose, Kyle; Sexton, Wade; Tachibana, Isamu; Kaimakliotis, Hristov; Jacob, Joseph; Dickstein, Rian; Linehan, Jennifer; Nieder, Alan; Bjurlin, Marc; Humphreys, Mitchell; Ghodoussipor, Saum; Quek, Marcus; O'Donnell, Michael; Eisner, Brian; Feldman, Adam; Lotan, Yair; Matin, Surena F

sustainable development goals

authors

publication date

  • May 1, 2023

published in

keywords

  • BACILLUS-CALMETTE-GUERIN
  • INVASIVE BLADDER-CANCER
  • Life Sciences & Biomedicine
  • MULTICENTER
  • NEPHROURETERECTOMY
  • Science & Technology
  • UPPER URINARY-TRACT
  • URETEROSCOPY
  • Urology & Nephrology
  • adjuvant
  • carcinoma
  • chemotherapy
  • endoscopy
  • mitomycin
  • topical drug administration
  • transitional cell

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 872

end page

  • 881

volume

  • 209

issue

  • 5